Status:
UNKNOWN
Comparison of Two Techniques for Epiretinal or Internal Limiting Membrane Peel
Lead Sponsor:
Michael E. DeBakey VA Medical Center
Collaborating Sponsors:
Baylor College of Medicine
Conditions:
Epiretinal Membrane
Vitreomacular Traction
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Epiretinal membranes (ERM) are cellular membranes on the surface of the retina that result in distortion of the vision (metamorphopsia), and decreased best-corrected visual acuity. They are most frequ...
Eligibility Criteria
Inclusion
- Epiretinal membrane with associated macular thickening or cystoid macular edema present;
- ETDRS best corrected visual acuity 20/50 or worse attributed to the effects of the epiretinal membrane;
- Pars plana vitrectomy/membrane peel planned for treatment of the epiretinal membrane;
- Patients older than 19 years of age;
- No co-existent retina pathology or optic neuropathy that may influence the visual field.
Exclusion
- Patient unwilling or unable to provide informed consent;
- Co-existing retina pathology (proliferative diabetic retinopathy, central retinal vein occlusion, branch retinal vein occlusion, central/branch retinal artery occlusion, ERM secondary to trauma, prior surgery for ERM);
- Co-existing lenticular opacity;
- Optic neuropathy causing a pre-existing visual field defect involving the central 10 degrees of vision.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
End Date :
May 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00892619
Start Date
December 1 2008
End Date
May 1 2010
Last Update
May 4 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine
Houston, Texas, United States, 77030
2
Michael Debakey VAMC
Houston, Texas, United States, 77030